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Prematurely born infants may be at risk, because of inadequate maturation of tissues. If
there are signs of preterm birth, it has become common practice therefore to treat either
antenatally the mother or postnatally the infant with glucocorticoids to accelerate tissue
development, particularly of the lung. However, this life-saving early glucocorticoid treat-
ment was found to increase the risk of adverse outcome in later life. In one animal study,
the authors reported a 25% shorter lifespan of rats treated as newborns with the synthetic
glucocorticoid dexamethasone, but so far this finding has not been replicated. After a brief
clinical introduction, we discuss studies in rodents designed to examine how perinatal
glucocorticoid action affects the developing brain. It appears that the perinatal action of
the glucocorticoid depends on the context and the timing as well as the type of admin-
istered steroid. The type of steroid is important because the endogenous glucocorticoids
cortisol and corticosterone bind to two distinct receptor populations, i.e., mineralocorticoid
and glucocorticoid receptors (GR), while synthetic glucocorticoids predominantly bind to
the GR. In addition, if given antenatally hydrocortisone is inactivated in the placenta by
11β-HSD type 2, and dexamethasone is not. With respect to timing, the outcome of glu-
cocorticoid effects is different in early vs. late phases of brain development. The context
refers to the environmental input that can affect the susceptibility to glucocorticoid action
in the newborn rodent brain; early handling of pups and maternal care obliterate effects
of post-natal dexamethasone treatment. Context also refers to coping with environmental
conditions in later life, for which the individual may have been programed epigenetically by
early-life experience. This knowledge of determinants affecting the outcome of perinatal
glucocorticoid exposure may have clinical implications for the treatment of prematurely
born infants.
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INTRODUCTION
The endogenous glucocorticoids cortisol and corticosterone pro-
mote the development of various tissues and organ systems during
development. However, in prematurely born infants this effect
of the steroids on maturation is abrogated resulting in a life-
threatening situation. Therefore, it has become common practice
to administer synthetic glucocorticoids such as dexamethasone to
accelerate maturation, particularly of lung tissue (1, 2). If given
antenatally to the mother the mortality of the prematurely born
infant is decreased. While the infants obviously benefit from peri-
natal glucocorticoids, the treatment reportedly can have negative
implications for later life outcome, particularly with respect to
dexamethasone or its analogs (3–5). This health risk at adulthood
includes impaired cardiovascular and immune functions as well
as deficits in motor and cognitive performance, altered emotional
reactivity, and neuroendocrine regulations.
In this contribution, data from animal and human studies with
respect to the perinatal (antenatal and post-natal) action of gluco-
corticoids are presented. The action of the naturally occurring glu-
cocorticoids is mediated by mineralocorticoid receptors (NR3C2,
MR) and glucocorticoid receptors (NR3C1, GR) (6, 7). These glu-
cocorticoids, cortisol, and corticosterone (the latter steroid only
in rodents), bind to MR and GR with an order of magnitude dif-
ference in binding affinity (6). This implies that corticosterone
and cortisol bind to the brain MR with high affinity resulting in
substantial occupation even during the very low circulating hor-
mone levels that are typically observed during the circadian trough
and in rodents during the early post-natal stress-hyporesponsive-
period (SHRP). These same steroids bind to GR only in adequate
amounts when in adult animals their concentration has increased
after stress and at the circadian peak. The membrane variants of
MR and GR also display a lower affinity suggesting that their rapid
effects preferably occur only at rising and high steroid concentra-
tions during stressful situations and circadian peaks (8). No data
exist on the role of these membrane variants during development.
The synthetic glucocorticoids preferentially bind to GR, usually
with high affinity (9).
We first review the human studies on antenatal activity of the
hypothalamic–pituitary–adrenal (HPA)-axis, development of cor-
ticosteroid receptors and the effect of antenatal glucocorticoid
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treatment. Then, after an overview of antenatal rodent data, we
will discuss the action of dexamethasone during the first post-natal
days (pnds) of the newborn rodent, since this resembles most the
antenatal treatment protocol in the human. Most animal studies
have been performed with male animals; if females are used this
is indicated. This contribution is concluded with a translational
perspective that may be helpful in the clinical management of
perinatal glucocorticoid treatment.
HUMAN STUDIES
ANTENATAL HPA-AXIS DEVELOPMENT
During pregnancy, the activity of the maternal HPA-axis gradu-
ally increases over time toward a state of hypercortisolism that
is caused by the steadily increasing production of corticotropin-
releasing hormone (CRH) in the placenta and fetal membranes
(10–12)). Fetal levels of CRH, adrenocorticotropic hormone
(ACTH), and cortisol also rise, but not as much as the mater-
nal values (13). Most of the cortisol present in amniotic fluid has a
maternal origin and has successfully traversed the placenta. How-
ever, this accounts for only 10–20% of maternal cortisol because
the remaining 80–90% is converted to inactive cortisone by the
enzyme 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) to
protect the fetus from excess glucocorticoid exposure (14, 15).
During the third trimester, fetal 11β-HSD2 levels fall and the fetus
is exposed to high levels of CRH and endogenous cortisol (16).
In this period, cortisol is able to exert its positive influence on the
maturation of several organ systems, in preparation of survival
after birth (17, 18).
ANTENATAL MR AND GR EXPRESSION
Very limited information is available on human MR and GR
expression patterns during gestation. Condon and colleagues
reported minimal expression of MR and GR in peripheral tis-
sues during gestational week 6, which becomes detectable from
gestational weeks 8–16, with in general higher GR compared to
MR expression (19). Noorlander et al. (20) studied MR and GR
mRNA expression in the hippocampus from gestational week 24–
34. They reported that both MR and GR mRNA are present during
this period, with higher MR compared to GR mRNA levels and lit-
tle change in expression levels over time (20). However, humans
are in part altricial species and antenatal MR and GR expression
appear to follow a pattern similar to that in guinea pigs and sheep
rather than mice and rats. When comparing rodent brain develop-
ment to human brain development, the last days of rat gestation
(day 22–23) resemble human fetal brain development in week
16–17 regarding relative aspects of neurogenesis, neuron size, and
number (21, 22).
ANTENATAL GLUCOCORTICOIDS IN THE CLINIC
In 1972, Liggins and Howie were the first to demonstrate the
beneficial effects of antenatal synthetic glucocorticoid treatment
in the prevention of respiratory distress syndrome of premature
infants (23). It is now known that treatment with the synthetic glu-
cocorticoids dexamethasone and betamethasone accelerates the
maturation process of several organ systems (e.g., lungs, heart,
and kidneys) and antenatal synthetic glucocorticoid has become
the standard treatment for women at risk of preterm delivery (1).
In short-term, antenatal synthetic glucocorticoids reduce neonatal
death, incidence of respiratory distress syndrome, cerebroventric-
ular hemorrhage, necrotizing enterocolitis, respiratory support,
intensive care admissions, and systemic infections in the first 48 h
of life (2).
There is not much information on the long-term consequences
of antenatal synthetic glucocorticoid treatment in humans.
Roberts and Dalziel reported in a 2006 Cochrane systematic
review, four follow-up studies into childhood and two into adult-
hood on the effect of a single course of antenatal glucocorticoid
treatment (2). No psychological differences were found between
antenatal glucocorticoid treatment and placebo for both children
and adults. Another Cochrane review failed to show any long-term
(adverse) effects of either single or repeated doses of antenatal
betamethasone (24).
Despite this positive news on the clinical outcome of perina-
tal synthetic glucocorticoid treatment in the short-term, there are
concerns about the potential negative long-term effects of antena-
tal overexposure. This is because of data from animal experiments
with these synthetic glucocorticoids or derived from endogenous
glucocorticoid action during stress (see below). Epidemiological
studies have shown an association between high maternal stress,
nutritional factors, or infections during pregnancy, which sug-
gested an association of perinatal overexposure to endogenous
glucocorticoid with mental disorders in later life. These include
retrospective studies in man, such as those involving children
born from Dutch mothers that were pregnant during the Dutch
“Hunger winter” of 1944–1945. The adults exposed as fetus to
these major stressors showed a higher incidence of schizophrenia
(25), affective disorder (26), and addiction (27) as well as meta-
bolic disorders (28). Furthermore, depression was associated with
maternal influenza infection (29) and autism with mothers suf-
fering from family problems (30). One review focused on animal
models derived from epidemiological studies to examine the ante-
natal influence of maternal stress and nutritional status (31). In
a meta-analysis of 60 human and 43 animal studies Beydoun and
Saftlas (32) concluded independent effects of antenatal and post-
natal outcomes. A vast literature is emerging on the outcome of
early post-natal adversity and abuse (33, 34). Attempts are under
way to ameliorate outcome using micronutrient supplements (35).
However, the consequences of treatment with the synthetic
glucocorticoids betamethasone and dexamethasone cannot be
directly compared to the impact of exposure to the endogenous
glucocorticoids cortisol and corticosterone. First, the synthetic
glucocorticoids are poor substrates for 11β-HSD2 and can pass the
placental barrier more readily than endogenous glucocorticoids
(36, 37). Second, the synthetic glucocorticoids bind the GR with
higher affinity than endogenous glucocorticoids (9). Third, the
synthetic glucocorticoids are GR-specific rather than MR-specific,
while cortisol and corticosterone bind with a 10-fold higher affin-
ity to MR compared to GR (6). And fourth, in the guinea pig MR
and GR both are involved in the induction of multidrug resistance
P-glycoprotein (P-gp) in the fetal blood–brain-barrier in response
to endogenous cortisol, aldosterone, and dexamethasone (38).This
finding suggests that upon repeated exposure to dexamethasone
access of the synthetic steroid itself may be hampered, because the
steroid is a substrate for the transporter (39–41). Regardless, the
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overall picture clearly indicates that glucocorticoid overexposure
has long-term consequences and the question is therefore rather
how these effects occur.
ANIMAL STUDIES
ANTENATAL MR AND GR EXPRESSION
The programing effects of glucocorticoids during fetal brain devel-
opment depend on the expression of MR and GR, which are time,
location, and species specific. A distinction can be made between
altricial and precocial species. Rats and mice are altricial species,
which are relatively underdeveloped when born, with critical brain
development occurring ante- and postnatally. In precocial species
such as guinea pigs and sheep critical brain development occurs
mostly antenatal. Primates including humans are considered a
mixture of altricial and precocial: in aspects of body develop-
ment they may be considered precocial, but behaviorally they are
altricial.
In rats, GR mRNA expression was found in e.g., hippocam-
pus, hypothalamus, cerebellum, raphe nuclei, locus coeruleus, and
olfactory bulb, in midgestation from gestational day E12.5 onward
(16, 42). At the end of the gestational period, when endogenous
levels of corticosterone are high and the fetal HPA-axis becomes
active, GR mRNA expression increases throughout the brain. MR
mRNA expression is more limited in the hippocampus, parts of
the hypothalamus and the superior colliculus piriform cortex, lat-
eral septum, brainstem, and pituitary and starts in late gestation,
3 days before birth (16). A similar expression pattern was seen in
mice (43–45).
In precocial species such as the guinea pig and sheep, a differ-
ent and more complex MR and GR expression pattern was found
(46–48). In guinea pigs, from gestational day 40 onward both MR
and GR mRNA is present in the cortex, hippocampus, and dentate
gyrus. In the period between gestational day 40 and 50, which is
60–75% of the total gestation length, GR mRNA levels increase
while MR mRNA levels decrease. GR mRNA in the hippocampus
increases to peak levels near term, while MR mRNA levels remain
consistently low. However, in the paraventricular nucleus (PVN),
GR mRNA levels are at peak level around gestational day 40 and
50 and show a large decline afterward (48).
ANIMAL MODELS OF ANTENATAL GLUCOCORTICOID EXPOSURE
Many experimental animal studies have demonstrated that gluco-
corticoid overexposure in utero, both endogenous and exogenous,
can have long-term effects on the offspring. Studies in rodents
have shown a relationship between antenatal glucocorticoid over-
exposure and signs of schizophrenia and depression, increased
anxiety and impaired learning and memory [see review in Ref.
(49)]. Antenatal glucocorticoid exposure in rats, guinea pigs, and
non-human primates caused permanently elevated baseline corti-
costeroid levels and increased corticosteroid levels in response to
stress (50–53). Excess antenatal glucocorticoids are also capable
of permanently altering MR and GR expression in multiple brain
areas (54–56) and can influence entire neurotransmitter systems
(49, 57). Experimental animal studies in comparison to studies
in man are far better capable of controlling variables, yet there
are many differences in methodology that can influence the out-
come, such as the type of stressor or synthetic glucocorticoid used
and timing and duration of exposure. Additionally, the effects of
glucocorticoid overexposure are also age, sex, and species spe-
cific, making it very difficult to translate the outcome of animal
experiments to the clinic.
POST-NATAL MR AND GR EXPRESSION
The ontogeny of the receptors has been carefully mapped over the
years using different techniques such as receptor binding assays,
immunocytochemistry, and in situ hybridization (58–62). In gen-
eral, MR is abundantly expressed in limbic-cortical regions, such
as hippocampus, septum, amygdala, and fronto-cortical regions
that have a function in processing of stressful information. With
all detection methods, MR density is found to be high already early
postnatally in mice and rats and localized in the nucleus. Pituitary
GR expression is also very high in early-life. In the brain, GR bind-
ing and mRNA expression gradually increase postnatally and at
weaning have reached about 50% of its adult level in the rat, and
already adult levels in the mouse.
Using immunocytochemistry, a profound change in transloca-
tion of GR was observed. Immediately after birth, high nuclear
immunoreactivity (ir) of GR occurs widespread over the rodent
brain, particularly in stress regulating centers such as PVN, the
ascending biogenic amine neurons, hippocampus, and amygdala
as well as fronto-cortical regions. Then, possibly because of the low
circulating levels of corticosterone during the SHRP, nuclear GR-ir
is very low before reappearing at around pnd 12. Interestingly, the
initial high GR-ir in the hippocampal CA3 pyramidal neurons and
the suprachiasmatic nucleus does not re-appear after pnd 7, sug-
gesting that the function of the latter nucleus now is entrained
by exposure to daylight rather than the circadian variation in
glucocorticoids from the mother (63, 64).
MR and GR in hippocampus show a profound downregulation
after prolonged maternal absence, while a procedure like handling
can induce their expression (65–67). Interestingly, MR and GR
density changes in parallel with the amount of maternal care the
pup is exposed to, a change in receptor concentration that can be
explained by the extent of methylation of the receptor gene promo-
tor region (68, 69). In a classical experiment (70), infant rats were
deprived of maternal contact for 24 h on pnd 3–4 and injected
with saline or ACTH1-24 at the end of the deprivation period.
They were then returned to their dams and weaned on pnd 21.
At pnd 48, they were sacrificed (24 h post adrenalectomy) and the
hippocampal MR and GR measured using an in vitro cytosol bind-
ing assay. Using this procedure in the male rats, deprivation and
deprivation+ACTH resulted in a reduction of GR. MR was also
significantly downregulated in the deprived males. In contrast, in
the female rats, saline injections in deprived female rats resulted
in increased GR capacity and ACTH injections lead to a further
up-regulation of the GR. None of the early manipulations influ-
enced the regulation of the MR in females. These results in adult
(7-week-old) rats indicate that the corticosteroid receptor systems
in the brain are sensitive to brief manipulations in maternal care
as well as corticosterone levels occurring early in development.
Moreover, there is a striking effect of sex.
ANIMAL MODELS OF ENDOGENOUS POST-NATAL GLUCOCORTICOID
VARIATION
In rodents, the first 2 weeks of life are characterized by a SHRP
during which mild psychological stressors or exogenous ACTH,
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that trigger a pronounced corticosterone rise in adulthood, pro-
duce only a weak adrenocortical response (71, 72). The SHRP
lasts from pnd 4 to 14 in rats, and from pnd 2 to 12 in mice
(73). During the SHRP, circulating corticosterone levels are low
and stable, but the steroid that circulates is free, since corticos-
teroid binding globulin (CBG) is not detectable during this period.
Also metabolism of corticosterone is changed, and hence the phar-
macodynamics of the hormone is different from that during the
previous perinatal days as well as the postweaning period. Because
of the lack of ACTH, the size of the adrenal is small and thus
the capacity to secrete steroids is very low, demonstrating that
adrenal hyporesponsiveness is actual the most proximal cause of
the SHRP (74).
The mechanism underlying this period of adrenal quiescence
has been examined thoroughly. It has been proposed that neural
connections involved in processing of stressful information are
still immature at the time. However, since adrenalectomy (ADX)
during the SHRP triggers a large ACTH response, it seems that
enhanced corticosterone feedback at the pituitary level is causal
for the SHRP. Moreover, Schmidt et al. (75) demonstrated that
the GR antagonist RU486, administered during the SHRP, trig-
gered a profound ACTH and corticosterone response. Next, mice
carrying a conditional knockout of the GR gene specifically tar-
geted at the pituitary corticotrophs showed excessive amounts of
circulating corticosterone during the SHRP (76). This elevated
corticosterone was resistant to dexamethasone suppression sug-
gesting that in the pup the pituitary is the primary feedback site
of stress-induced HPA-axis activity. Indeed, a single exposure to
a psychological stressor is capable to mount a central response
in c-fos and CRH, but the adrenal remains quiescent under these
conditions (77).
It is important to realize that GR-mediated feedback is in oper-
ation to maintain the SHRP and this phenomenon by definition
only can be revealed in the context of a stressor. Hence, administra-
tion of RU486 in saline did not trigger a stress response and there-
fore no further disinhibition by the GR antagonist. If RU486 was
administered in polyethylene glycol (PEG) as solvent, an immune
response caused by inflammation at the injection site occurred that
was sufficient to trigger adrenocortical corticosterone secretion
revealing the effect of the antagonist (78).
Thus, during the SHRP, corticosterone inhibits the stress-
induced HPA-axis activity primarily via a pituitary feedback site.
The GR-mediated mechanism maintaining the SHRP can be
revealed by pituitary GR knockout or GR antagonist treatment,
but only if there is a corticosterone rise after stress. In case of
resting conditions when GR blockade cannot operate because cor-
ticosterone levels are too low, the quiescence of the HPA-axis is
maintained via a centrally driven MR mechanism. These MR’s
operate brain circuits appraising salient information as they do
during adulthood (78).
MATERNAL CARE AND NOT DEXAMETHASONE EXERTS LONG-TERM
HPA-AXIS CONTROL
There is evidence that the effects of dexamethasone on the devel-
oping brain precede independent of psychosocial and attachment
effects. The experiments were inspired by the seminal studies of
Levine in the 1950’s demonstrating that daily handling of rat pups
attenuated HPA-axis activity and emotional reactivity in adult-
hood, an effect that could be mimicked by enhanced maternal care
(71, 72). MR and GR also respond; both handling and maternal
care induced MR and GR, probably because of enhanced demethy-
lation of the receptor gene (68, 79, 80). The opposite outcome
was reached under conditions of prolonged maternal absence, a
procedure that has become known as maternal deprivation.
In response to 24 h of maternal deprivation of rat or mouse
pups ACTH and corticosterone initially both rise during the first
8 h of maternal absence. Subsequently, the rise of corticosterone
continues and reaches maximal levels after 24 h, while ACTH lev-
els normalize for the remainder of the 24 h period. With the rise of
corticosterone, the pituitary pro-opiomelanocortin (POMC) and
CRH- and GR mRNA levels decrease in the PVN (66). If these 24-
h deprived pups are exposed to an injection stressor a profound
response occurs in pituitary ACTH and c-fos mRNA in the PVN.
Amazingly, the pituitary ACTH and PVN c-fos response is nor-
malized after stroking the pups for 45 s every 8 h with a warm wet
artist brush in the anogenital region, mimicking maternal lick-
ing and grooming (81). For normalization of the corticosterone
and the PVN GR mRNA response feeding is required in addition
to stroking. Interestingly, dexamethasone (100µg/kg) administra-
tion completely inhibits the ACTH and corticosterone response,
but does not affect the central responses to maternal deprivation
and the stressor (81) (Figure 1).
This differentiation between the effects of behavioral manip-
ulations and the action of dexamethasone also persists. In a
subsequent experiment, the rats deprived from pnd 11 to 12
for 24 h were pre-treated with dexamethasone to suppress the
corticosterone response to maternal deprivation. Another group
was only stroked for 45 s every 8 h or stroked+ fed at that
time, the latter procedure like dexamethasone also suppresses the
deprivation-induced HPA-axis activity. At 20 days of age, the pre-
viously deprived+ dexamethasone-treated animals did not differ
in their endocrine and central responses. However, feeding and
stroking did normalize the persistent effect of maternal depriva-
tion on ACTH and corticosteroid receptors. Hence this study not
only shows a lack of a persistent effect of dexamethasone, but
also that the suppression of corticosterone by dexamethasone has
no long-term consequences. It is the re-instatement of specific
aspects of maternal care that counts in the long-term control of
neuroendocrine function (82).
PUPS BECOME USED TO REPEATED MATERNAL SEPARATION
That the central components of the stress response are already in
operation during the SHRP can be demonstrated also in another
way. If the 24-h maternal deprivation at pnd 3–4 was split into three
episodes of each 8 h per day from pnd 3 to 5, we observed during
the first separation the predicted rise in ACTH and corticosterone
secretion. These neuroendocrine responses disappeared with the
next separations as if the pup has learned to anticipate the return of
the dam. When the anti-glucocorticoid RU486 was administered
the response to the first separation was further enhanced, but the
effect of the antagonist declined in the second and was abolished
after the third separation on pnd 5. In contrast, a MR antagonist
decreased corticosterone levels after the first, but increased corti-
costerone secretion after the third separation. Surprisingly, while
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FIGURE 1 | Basal CRH stress-induced (30min after saline injection) c-fos
and basal GR mRNA expression in the PVN of 12-day-old pups. (A) Effect
of dexamethasone (DEX): the deprived (DEP) group had been deprived 24 h
before testing (n=10–12 per group). Non-deprived (NDEP) animals served as
controls. The DEX animals had received a dexamethasone injection at the
onset of deprivation (or equivalent time for NDEP) of 100µg/kg BW. NT
animals had received a saline injection instead of a DEX injection, *p<0.05,
significant from NDEP counterparts. (B) Effect of feeding and stroking: litters
were deprived for 24 h on P11, during which time they were either left
undisturbed (ISO), stroked (STROK), or stroked and episodically fed (F & S)
(n=10–12 per group). NDEP animals served as controls, *p<0.05, significant
from NDEP counterparts. [Reprinted with permission from Ref. (81)].
the newborn becomes used to repeated daily maternal separation
as reflected by its normalization of basal HPA-axis activity to SHRP
levels, the pups continue to respond to a novelty stressor (78, 83).
The importance of this information cannot be emphasized
enough. It first shows that the pups as young as they are already
have learned to cope with maternal absence. Their stress system
stays on alert, however, and this process seems to involve the func-
tioning of the MR. In the adult, this receptor has been shown to be
important in controlling the circuits underlying the appraisal of
salient events, vigilance, and emotional reactivity, and apparently
this salience system already seems to be in operation in the new-
born. In the adult amygdala, corticosterone is capable to impose
metaplasticity in the amygdala (8, 84, 85). It appears that also in
the pup the cooperative MR- and GR-mediated actions of corti-
costerone can enhance a lasting activity in the amygdala as can be
read from the increased c-fos activity that persists into later life
(86, 87). Whether glucocorticoids acting via GR are capable early
postnatally to reallocate energy resources to circuits underlying
executive function as they do in the adult, remains to be demon-
strated (7, 88–90). That at this early age likely the salient rather
than the fronto-cortical network operates also has become appar-
ent from studies demonstrating the efficacy of the MR-dependent
network in response to corticosterone during the SHRP (91).
In these experiments not only the duration of the separation
leaves its marks, also the timing is relevant. If 24 h of maternal
separation occurs at pnd 3–4, an enhanced stress-induced ACTH
and hypothalamic c-fos response is observed at pnd 20. Depriva-
tion for 24 h at pnd 11–12, however, results in the opposite, an
attenuated ACTH and c-fos response to stress 8 days later at pnd
20 (92). The corticosterone response to stress in the pnd 20 pups
deprived at either pnd 3 or 11 was not different from the non-
deprived controls, however. Accordingly, the persistent alterations
in central and ACTH responses as a function of pnd of deprivation
are not reflected in corticosterone levels.
In conclusion, the findings reported in the previous para-
graphs demonstrate that post-natal dexamethasone effects are
overridden by centrally regulated processes that underlie coping
of the pup with changing conditions. The newborn is aware of
these changing conditions and the corticosterone receptor system
seems already to cooperate with the sympathetic nervous system
in organizing the salience neuronal network response expressing
signs of appraisal, attention, vigilance, and emotional reactivity.
Why this network does not seem to be affected by dexametha-
sone may be because the synthetic steroid does not bind to the
MR, which is one of the initial drivers of the salience network
(Figure 2).
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FIGURE 2 | Corticosterone, dexamethasone, and the rat SHRP. (A) Mild
stress+handling: corticosterone maintains quiescence in the HPA-axis, but
the brain responds to the mild stressor. Dexamethasone acts on brain and
pituitary via GR. Handling obliterates long-term effects of dexamethasone
(93). (B) Maternal separation and mild stress: stressful information from the
brain overrides the pituitary feedback action of corticosterone. The elevated
corticosterone acts via MR and GR to modulate programing of limbic brain
pathways (87). The darker gray tone indicates enhanced limbic activity by
increased sensory and corticosterone input. (C) Feeding and stroking the
maternally separated rat inhibits the brain, pituitary, and adrenal response to
the stressor. Dexamethasone also blocks the pituitary–adrenal axis but does
not give the same outcome as feeding and stroking (81).
ANIMAL MODELS OF POST-NATAL GLUCOCORTICOID EXPOSURE
Animal models of post-natal treatment with dexamethasone have
demonstrated profound effects on later life outcome. Among the
most serious outcomes is the finding that the lifespan of early
dexamethasone-treated rats was reduced with 25% (94). The cause
of death was cardiac and kidney failure, while also auto-immunity
was noted. Impaired cognitive functions were also reported. The
dexamethasone-treated animals had deficits in spatial learning and
showed disturbances in the neuroendocrine response pattern to
stress (95, 96).
We started a research project with the aim to ameliorate the
putative negative prognosis of early dexamethasone treatment. In
the first series of experiments, we have used an intracerebroven-
tricular (ICV) administration of the anti-glucocorticoid RU486
to protect the brain against early dexamethasone treatment (97).
We adopted the treatment regimen of tapering daily doses of
dexamethasone-21-phosphate during the first 3 pnds, because it
is thought to resemble the clinical administration of the drug:
0.5µg/g pup on pnd 1 followed by 0.3 and 0.1µg on pnd 2 and
3. The treatments were preceded by an ICV administration of
0.1 ng RU486. First, we examined with immunostaining for the Ki-
67 marker the neuronal proliferation in the hippocampal dentate
gyrus and found a profound reduction the day after dexametha-
sone treatment, which however was not inhibited by GR block-
ade. These effects were normalized by pnd 10. We also analyzed
astrogliosis on the basis of glial fibrillary acidic protein (GFAP)
immunocytochemistry and found a significant suppression in the
corpus callosum 1 week after dexamethasone administration, that
was blocked by pre-treatment with RU486 (Figure 3).
These data are consistent with previous studies showing that
dexamethasone can transiently suppress neuronal proliferation
and astrogliosis and that the effects are reversible possibly because
of rebound effect later during development (98). The data also
show that some of these effects can be prevented by local GR
blockade in the hippocampus.
LATER LIFE OUTCOME
We were unable to reproduce the striking negative outcome of
early post-natal dexamethasone treatment and discovered several
factors that may account for this discrepancy with the published
studies. First, in our studies we have used Long Evans rats, while
most other studies were performed with Wistars or Sprague Daw-
ley rats. More importantly, however, might have been differences
in the design of the studies. While for instance Kamphuis et al. (96)
used a whole litter design, we have consistently used a split-litter
design with both dexamethasone and saline treated animals within
every litter, to assure similar treatment conditions for each individ-
ual animal. Moreover, in the course of our experiments we noted
that the handling procedure, required to inject and mark the pups,
actually triggered bouts of enhanced maternal care that are known
since long to reduce emotional reactivity and stress responsivity
of the pups in later life. Indeed in a comparative study we found
that a non-handled group of rats was more impaired in cognitive
function than the handled dexamethasone and saline groups that
each did not differ significantly from each other (93, 99).
Then in a controlled study,we examined whether daily handling
actually could prevent adverse effects of post-natal dexametha-
sone treatment (93). Thus four groups were compared: first, a
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FIGURE 3 | Short-term effect of post-natal dexamethasone. (A) Body
weight on pnd 1–10 of saline (SAL) and dexamethasone (DEX) treated
animals with intracerebroventricular (ICV) treatment of the glucocorticoid
antagonist RU486 (mifepristone, MIF). DEX treatment significantly reduced
body weight; this effect is not prevented by central mifepristone
pre-treatment. (B) DEX treatment resulted in accelerated eye opening; on
pnd 8–12 DEX treated animals show enhanced level of eye opening
compared to SAL treated animals. Data represent mean±SEM, *p<0.05,
**p<0.01. (C) Number of glial fibrillary acidic protein (GFAP)-positive cells in
the corpus callosum 7 days post treatment in SAL and DEX treated animals
with ICV MIF pre-treatment. **Interaction between subcutaneous (SC) and
ICV treatment p<0.01. #Interaction between SC and ICV treatment
p<0.10. (D) Density of Ki-67 positive cells in the dentate gyrus of the
hippocampus 24 h post treatment in SAL and DEX treated animals with ICV
MIF pre-treatment. **Main effect of DEX treatment p<0.01; *main effect
of DEX treatment p<0.05. [Reprinted with permission from Ref. (97)].
saline and a dexamethasone group that was only handled briefly
for injections on the first 3 days of life and afterward was left undis-
turbed until weaning. Second, a saline and a dexamethasone group
that was handled daily until weaning for 15 min. Eye opening was
accelerated in dexamethasone-treated animals from day 12 to 8;
a phenomenon that could not be evaluated in the non-handled
groups. Dexamethasone treatment reduced body weight gain by
20% during the first 3 weeks of life. These differences in body
weight lasted up to 10 months of age. Maternal care was enhanced
the first week of life in the handled groups. This effect was only
observed post-reunion when licking and grooming was increased
from about 8 to 12% of the time. These differences in maternal care
are known to have profound effects on later life outcome (100).
A number of behavioral observations were made over the
next 10 months. Handling improved impaired spatial learning
of the dexamethasone-treated non-handled animals the T-maze
(Figure 4). In another hippocampal-associated spatial learning
test, the water maze, handling reduced the susceptibility to the
impact of dexamethasone treatment. Furthermore, in a fear condi-
tioning paradigm the acquisition of fear as expressed by a freezing
response was reduced in both handling groups both immediately
after the shock as well as upon re-exposure to the context after
24 h, without any effect of dexamethasone treatment, which is in
agreement with Kamphuis et al. (95). Handling had a beneficial
effect on pre-pulse inhibition at the 2 dB level in saline treated ani-
mals, without affecting dexamethasone-treated animals. Finally,
both dexamethasone treatment and handling resulted in enhanced
negative feedback of the stress-induced corticosterone response
and reduced startle reactivity (Figure 4). Thus, we find that
the handling procedure, which enhances maternal care received
by the newborn, was able to attenuate specific dexamethasone-
induced impairments in the behavioral phenotype of the adult
animals (93).
DEVELOPMENTAL ORIGIN OF DISEASE
One may wonder how the outcome of early dexamethasone expo-
sure may fit into the theory on the developmental origin of health
and disease (DOHaD). This theory has its basis in the Barker
hypothesis on the relationship between low birth weight and health
outcome in later life and refers to the efficiency of food and energy
transfer of the mother to the fetus (101). There can be many rea-
sons for this deficit including the stressful events occurring antena-
tally and even the pre-implantation hormonal conditions (102).
Ovarian hyperstimulation is a stressful condition that compro-
mises vascularization of the blastocyst implantation site and hence
caused decreased supply of nutrients. Ovarian hyperstimulation
is commonly used in the generation of transgenic mice and might
therefore have introduced a bias in all studies involving mutant
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FIGURE 4 | Long-term outcome of post-natal dexamethasone.
(A) All groups except dexamethasone non-handled (DEX NH) spent
significantly more time in the new compared to the familiar arm
during re-exposure to T-maze. Data represent mean±SEM,
*p<0.05, **p<0.01. (B) Cortcosterone (CORT) levels before,
during, and following exposure to 10 min restraint stress. Both
handling and DEX treatment result in enhanced negative feedback
of the HPA-axis at t =120 min. Data represent mean±SEM.
Time×drug treatment×handling interaction p=0.01, *p<0.05
(from Ref. (93)).
mice (103, 104), particularly if urinary rather than recombinant
gonadotropins have been used.
The DOHaD theory describes how experiences during early-
life from blastocyst implantation, to fetal and post-natal life into
puberty may induce developmental changes that affect the suscep-
tibility to often comorbid cardiovascular and metabolic diseases
as well as mental disorders in later life. It is thought that stressful
experiences during early-life can modulate the genetic program-
ing of specific brain circuits underlying emotional and cognitive
aspects of behavioral adaptation. Although such a scenario implies
multiple hits we have used for practical reasons to restrict the
hits to three main categories: hit 1: genetic pre-disposition, hit
2: early-life experiences and hit 3: experiences during puberty
(87, 105, 106).
CUMULATIVE STRESS EXPOSURE: THE MATCH/MISMATCH THEORY
It was found that either each subsequent hit accumulates damage
and predisposes for disease or that gene X environment in early-
life (hit 1× hit 2× hit 3) prepares for coping with challenges in
later life. The latter situation predicts that experiencing adversity
in early-life actually promotes coping with similar adverse con-
ditions in later life. These findings led to the formulation of the
predictive adaptive capacity or match/mismatch hypothesis (107).
The latter hypothesis predicts increased vulnerability in case of a
mismatch between early-life experiences that have re-programed
the behavioral repertoire to cope with the actual circumstances the
individual is facing in later life (108).
In our research, we observed that male rats that had experienced
as pups abundant maternal care were well prepared at adulthood
to execute cognitive tasks under relatively mild stressful condi-
tions. Their hippocampus showed signs of extensive dendritic
arborizations richly endowed by synaptic boutons and in vitro
an efficient long-term potential (LTP) response could be evoked
from these hippocampal circuits. However, under more stressful
conditions this well-groomed offspring performed poorly, a find-
ing that gives support to the match/mismatch hypothesis (100,
109–113).
What determines whether early-life adversity actually prepares
for life ahead or for cumulative damage and enhanced vulnerability
is not known. One line of research suggests that the genotype
is critical. When newborn rats of a line that was genetically
selected for enhanced responsiveness of the dopamine system by
apomorphine-induced gnawing were deprived repeatedly from
maternal care for a prolonged period, but only if the pups had also
experienced a stressor (87). Subsequent exposure to isolation rear-
ing during puberty promoted at adulthood signs of schizophrenia
such as an impaired PPI response.
How early-life dexamethasone treatment fits into these hypoth-
esis is not known. It is conceivable that the reduced body weight
after pre- and post-natal dexamethasone exposure bears some rela-
tionship with the phenotype that led to the Barker and the DOHaD
theories, but this needs to be investigated. At the same time, how-
ever, we also presented evidence that with respect to the brain the
dexamethasone effects are overridden by maternal factors. This
was demonstrated in two ways. First, in the deprived rat the nor-
malization of HPA-axis activity persisted by mimicking maternal
care through feeding and stroking the pups, but not if dexametha-
sone was given that also causes like maternal care an immediate
suppression of the HPA axis. Second, adverse effects of dexam-
ethasone on higher brain functions were ameliorated by neonatal
handling causing enhanced maternal care.
MECHANISM
How do these maternal factors override the lasting effects of
dexamethasone? Research in the past decade has clearly estab-
lished that early-life experience may cause stable changes in his-
tone acetylation and DNA methylation. These findings have led
to the recognition of the epigenome as the molecular basis for
altered plasticity in organ systems including the brain (114).
These epigenomic signatures are a determinant of plasticity in
neuronal networks underlying later emotional expression and
cognitive performance, and seem a significant factor in the precip-
itation of stress-related mental disorders such as depression and
addiction (115).
In recent years, DNA methylation of HPA-axis genes, among
others the promotor regions of the GR (80, 116), the vasopressin
(VP) gene (117), and 11βHSD (118) was observed. In particu-
lar, the epigenetic change in GR was found associated with a
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behavioral response pattern and HPA-axis setpoint in later life,
and therefore is considered to represent some sort of “molecu-
lar memory” for salient events (68). Hence, decreased expression
of GR in the hippocampus was found associated with emotional
neglect in early-life (80, 119). Suderman et al. (116) recently stated
that a global epigenetic signature of early-life experience becomes
apparent that is maintained across species and centered around
GR gene regulation, while more detailed analysis of the methyla-
tion profile may reveal more subtle intrinsic differences between
species. Indeed, altered responsiveness in gene expression is main-
tained until adulthood and reflected in transcriptome analysis of
subregions of the hippocampus (120). In this type of analysis it
appeared already in the adult animals that the history of chronic
stress experience causes a profound change in the transcriptional
response to an acute corticosterone or stress stimulus with an
overrepresentation of genes involved in chromatin remodeling,
epigenetic processes, and cell adhesion (121–123).
The mechanism by which perinatal dexamethasone exposure
causes long-term effects is not completely understood. Recent
studies suggest that these long-term effects are possibly medi-
ated through GR-activated epigenetic modulations such as DNA
methylation and histone acetylation. Matthews and colleagues
have extensively studied the epigenetic modifications associated
with antenatal synthetic glucocorticoid treatment in the guinea
pig. They observed that during the endogenous glucocorticoid
surge in late gestation considerable changes in global DNA methy-
lation in several organ systems take place that affect the expres-
sion of genes involved in the methylation process. Betamethasone
administered before the natural glucocorticoid surge also affected
global methylation and expression of methylation-related genes,
though slightly different compared to the endogenous surge, and
in addition affected histone-3 lysine 9 acetylation (124, 125).
The effects of betamethasone treatment not only persisted into
adulthood but also into the next generation (124).
In the male hippocampus it was also shown that concurrent
with changes in DNA methylation, GR DNA binding was altered
during both the endogenous glucocorticoid surge as well as syn-
thetic glucocorticoid treatment (126). Though, this study clearly
shows a relationship between altered GR DNA binding and epige-
netic changes in gene expression, further research is necessary to
provide conclusive evidence for a GR-mediated mechanism of epi-
genetic modification. This type of ChIP-seq analysis of GR binding
to the hippocampal genome of ADX rats recently identified in the
adult rat hippocampus 2460 significant binding sites of which 40%
were associated with GRE’s in promoter regions (127).
CONCLUDING REMARKS
This contribution was focused on the mode and mechanism
of action in the brain of perinatal dexamethasone administra-
tion using pre- and post-natal animal models. This topic is of
relevance because glucocorticoids are critical for survival of pre-
maturely born infants. The glucocorticoid is required to ensure
adequate maturation of in particular lung tissue. Regarding the
mode of action the timing of glucocorticoids is important. If
given preterm to the mother the synthetic glucocorticoids are
used in a restricted number of courses [see Cochrane data base,
(128)]. Hydrocortisone is ineffective preterm since the hormone
is largely inactivated by 11β-HSD2 and does only poorly pass the
placenta barrier. Postnatally hydrocortisone is used and report-
edly there is so far no noticeable adverse outcome in later life
(129). The underlying mechanism of the steroid effects depends
on epigenetic modulation of the stress response system and pos-
sibly the changes in plasticity of limbic-forebrain glucocorticoid
target regions.
The rodent is frequently used to examine adversity of dex-
amethasone treatment, because it is an altricial species and pnd
1 in the rat resembles the developmental stage at the beginning
of the third trimester of human pregnancy. Alternatively, guinea
pigs are used to mimic antenatal administration of dexametha-
sone to pregnant females. Here, we have discussed in extenso the
role of glucocorticoids in development of the brain in relation to
the HPA-axis. Some authors reported alarming effects of perinatal
dexamethasone on health and brain development even causing
a life shortening of 25% (94). However, we and others (130)
were unable to find these detrimental effects, probably because
our design included enhanced levels of maternal care. Using two
different approaches, we demonstrated that such maternal care
effects override dexamethasone effects in the brain and the HPA-
axis. Hence, other approaches based on environmental input may
be beneficial. For instance, in rats environmental enrichment dur-
ing puberty appeared to neutralize the adverse outcome in the
offspring of antenatally stressed pregnant dams (131).
Hence context is capable to modulate the outcome of perina-
tal glucocorticoid action. The context becomes manifest in two
ways. First, maternal care and probably other contextual factors
such as e.g., environmental enrichment are capable to modulate
the outcome of glucocorticoid action, possibly by an epigenetic
machinery. Second, context is equally important in later life where
it either does or does not match the phenotype shaped by early
experiences in sensitive windows of brain development during
early post-natal life and puberty. Probably depending on genotype
and epigenomic signature susceptibility to stress-related disorders
may develop. Because of this interaction between dexamethasone-
induced effects and experience-related factors, behavioral inter-
ventions appear to be crucial in the clinical management of
preterm babies (132–134).
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